ReVance Therapeutics (Mountain View, CA) a clinical-stage biopharmaceutical company focused on dermatology and aesthetic medicine, closed a $25.6M Series D financing. Particpants have included Essex Woodlands Health Ventures, Vivo Ventures, Technology Partners, Shepherd Ventures, Palo Alto Investors, Bio*One Capital and Pac-Link Venture.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Kythera Biopharmaceuticals (Calabasas, CA) a clinical-stage biopharmaceutical company focused on aesthetic dermatology, closed a $10M Sereis C financing, bringing the total round to $40M. Participants include Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, BBT Capital Management, JAFCO Ventures and Altitude Life Science Ventures.

MyoScience, (Redwood City, CA) an aesthetic medicine startup, closed a $10.4M Series B financing. Participants include Nexus Medical Partners, Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures.

Eleme Medical (Merrimack, NH) commercial-stage aesthetics company focused on the development of tools for the reduction of cellulite, closed a $18M Series C financing. Participants include Capital Partners. New investor Hambrecht & Quist Capital Management and returning investors Three Arch Partners and EDF Ventures participated.

Myoscience (Redwood City, CA) early-stage biotech focused on dermatology and aesthetic medicine closed a $8.4M Series B financing. Participants include Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures.